Ganjei P
Department of Pathology, University of Miami School of Medicine, Florida, USA.
Clin Lab Med. 1995 Sep;15(3):705-26.
FNA cytology has been shown to be highly accurate in diagnosing malignant tumors. In gynecology, an overall accuracy of 94.5% in the differentiation between benign and malignant tumors has been reported. Despite many controversial views regarding its safety, aspiration cytology has been accepted as an innocuous procedure that can be accomplished with minimal discomfort or complications and, in association with laparoscopy, assist in the management of ovarian cysts and masses. Although FNA cannot be considered the first-hand diagnostic procedure for ovarian cancer in postmenopausal patients, it may be extremely helpful in young women, even during pregnancy, to safely differentiate functional and other benign ovarian cysts from malignant ones. In postmenopausal women, especially those in the high risk group for surgical procedures and those undergoing a "second look" intervention following radiation or chemotherapy, aspiration cytology may provide sufficient information to warrant abandoning unnecessary surgery. During laparotomy for suspected unilateral disease, FNA may provide sufficient data about the opposite ovary to allow that organ to remain in place, thus preserving its function in a young patient. The pathologist must be familiar with the cytology of normal pelvic structures and the diagnostic criteria used to differentiate benign from malignant lesions, as well as potential diagnostic pitfalls, such as interpretation based on very few cells or the absence of appropriate clinical information. Although proper classification of ovarian masses can be achieved through FNA, the pathologist should be aware of its limitations, such as difficulties in differentiating adenomas from non-neoplastic cysts, and tumors of low malignant potential from well-differentiated carcinomas. Descriptive histologic terminology should be applied, and terms such as "suspicious" or "atypical" avoided. The aspirated material may not only be used for the diagnosis and classification of ovarian neoplasms, it may also be used for DNA analysis, detection of estrogen receptors and other prognostic markers, thus providing information regarding biologic behavior of the tumors. Finally, it is hoped that aspiration of ovarian lesions routinely detected by sonography, in elderly women or those with a strong family history of ovarian cancer, will allow the physician to accomplish detection of early ovarian cancer.
细针穿刺抽吸活检(FNA)细胞学检查在诊断恶性肿瘤方面已被证明具有高度准确性。在妇科领域,据报道在鉴别良性和恶性肿瘤方面总体准确率为94.5%。尽管对于其安全性存在许多有争议的观点,但抽吸细胞学检查已被视为一种无害的操作,能够在极少不适或并发症的情况下完成,并且与腹腔镜检查相结合,有助于卵巢囊肿和肿块的处理。虽然FNA不能被视为绝经后患者卵巢癌的首要诊断方法,但在年轻女性中,甚至在怀孕期间,它对于安全地区分功能性和其他良性卵巢囊肿与恶性囊肿可能极为有用。在绝经后女性中,尤其是那些手术风险高的人群以及接受放疗或化疗后进行“二次探查”干预的患者,抽吸细胞学检查可能提供足够的信息,从而避免不必要的手术。在因怀疑单侧疾病而进行剖腹手术时,FNA可能提供有关对侧卵巢的足够数据,以便保留该器官,从而在年轻患者中保留其功能。病理学家必须熟悉正常盆腔结构的细胞学以及用于区分良性与恶性病变的诊断标准,以及潜在的诊断陷阱,例如基于极少细胞进行的解读或缺乏适当的临床信息。尽管通过FNA可以实现卵巢肿块的正确分类,但病理学家应意识到其局限性,例如难以区分腺瘤与非肿瘤性囊肿,以及低恶性潜能肿瘤与高分化癌。应使用描述性组织学术语,避免使用“可疑”或“非典型”等术语。抽吸物不仅可用于卵巢肿瘤的诊断和分类,还可用于DNA分析、雌激素受体及其他预后标志物的检测,从而提供有关肿瘤生物学行为的信息。最后,希望对老年女性或有卵巢癌家族史的女性中通过超声常规检测到的卵巢病变进行抽吸,能使医生实现早期卵巢癌的检测。